Skip to main content

Shareholders

Shareholders

Since its inception, ELSALYS BIOTECH has benefitted from the ongoing commitment and support of leading investors

Breakdown of share capital (% of total number of shares)

*IM Europe, subsidiary of INSTITUT MERIEUX

STAY IN TOUCH WITH OUR LATEST NEWS

Subcribe to our newsletter

This website uses cookies to track its audience and improve its content.

By continuing to browse this website, you agree to the use of such cookies.